Cerdelga
eliglustat
Listed by Genzyme Corporation
- Strength
- 84 mg/1
- Form
- Capsule
- Route
- Oral
- Class
- Glucosylceramide Synthase Inhibitor
What it contains
- Eliglustat 84 mg/1
FDA record
| Dosage form | Capsule |
|---|---|
| Route | Oral |
| Drug class | Glucosylceramide Synthase Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 58468-0220 |
| FDA application | NDA205494 |
| RxNorm concept | 1547225 |
| Package sizes listed | 2 |
| Marketed since | September 2014 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.